483 related articles for article (PubMed ID: 17889387)
1. Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia.
Ishikawa A; Yoshida H; Metoki N; Toki T; Imaizumi T; Matsumiya T; Yamashita K; Taima K; Satoh K
Neurosci Res; 2007 Dec; 59(4):406-12. PubMed ID: 17889387
[TBL] [Abstract][Full Text] [Related]
2. Edaravone improves the expression of nerve growth factor in human astrocytes subjected to hypoxia/reoxygenation.
Yoshida H; Metoki N; Ishikawa A; Imaizumi T; Matsumiya T; Tanji K; Ota K; Ohyama C; Satoh K
Neurosci Res; 2010 Mar; 66(3):284-9. PubMed ID: 19954754
[TBL] [Abstract][Full Text] [Related]
3. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro.
Xu Q; Wang S; Jiang X; Zhao Y; Gao M; Zhang Y; Wang X; Tano K; Kanehara M; Zhang W; Ishida T
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):624-31. PubMed ID: 17581219
[TBL] [Abstract][Full Text] [Related]
5. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
6. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
Zhu DM; Li DC; Zhang ZX; Zhang XY
Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin stimulates vascular endothelial growth factor production by hypoxia-inducible factor-1alpha upregulation in endothelial cells.
Nishimoto-Hazuku A; Hirase T; Ide N; Ikeda Y; Node K
J Cardiovasc Pharmacol; 2008 Mar; 51(3):267-73. PubMed ID: 18356691
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effect of siRNA targeting HIF-1alpha on differentiation of peripheral blood endothelial progenitor cells].
Jiang M; Wang CQ; Wang BY; Huang DJ
Ai Zheng; 2005 Nov; 24(11):1293-300. PubMed ID: 16552951
[TBL] [Abstract][Full Text] [Related]
10. Upregulated hypoxia-inducible factor-1 DNA binding activity to the vascular endothelial growth factor-A promoter mediates increased vascular permeability in donor lung grafts.
Abraham D; Krenn K; Seebacher G; Paulus P; Klepetko W; Aharinejad S
Ann Thorac Surg; 2004 May; 77(5):1751-5. PubMed ID: 15111179
[TBL] [Abstract][Full Text] [Related]
11. Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury.
Zhang P; Li W; Li L; Wang N; Li X; Gao M; Zheng J; Lei S; Chen X; Lu H; Liu Y
Neuroscience; 2012 Jan; 201():297-306. PubMed ID: 22116052
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
[TBL] [Abstract][Full Text] [Related]
13. Quantitative RT-PCR assays of hypoxia-inducible factor-1alpha, erythropoietin and vascular endothelial growth factor mRNA transcripts in the kidneys with regard to the cause of death in medicolegal autopsy.
Zhao D; Zhu BL; Ishikawa T; Li DR; Michiue T; Maeda H
Leg Med (Tokyo); 2006 Oct; 8(5):258-63. PubMed ID: 16963303
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha.
Kim HJ; Chung H; Yoo YG; Kim H; Lee JY; Lee MO; Kong G
Mol Cancer Res; 2007 Apr; 5(4):321-9. PubMed ID: 17426247
[TBL] [Abstract][Full Text] [Related]
15. Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells.
Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Leung E; Maclennan S; Borea PA
Biochem Pharmacol; 2006 Jun; 72(1):19-31. PubMed ID: 16682012
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor expression by hyalocytes and its regulation by glucocorticoid.
Hata Y; Sassa Y; Kita T; Miura M; Kano K; Kawahara S; Arita R; Nakao S; Shih JL; Ishibashi T
Br J Ophthalmol; 2008 Nov; 92(11):1540-4. PubMed ID: 18952656
[TBL] [Abstract][Full Text] [Related]
17. [Expression of hypoxia-inducible factor-1alpha, vascular endothelial growth factor and sFlt-1 in preeclampsia placenta].
Sun SG; Shen N; Zheng YH; Shang T
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):440-4. PubMed ID: 17083805
[TBL] [Abstract][Full Text] [Related]
18. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.
Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Simioni C; Leung E; Maclennan S; Baraldi PG; Borea PA
Mol Pharmacol; 2007 Aug; 72(2):395-406. PubMed ID: 17488804
[TBL] [Abstract][Full Text] [Related]
19. Effects of YC-1 on hypoxia-inducible factor 1-driven transcription activity, cell proliferative vitality, and apoptosis in hypoxic human pancreatic cancer cells.
Zhao Q; Du J; Gu H; Teng X; Zhang Q; Qin H; Liu N
Pancreas; 2007 Mar; 34(2):242-7. PubMed ID: 17312464
[TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor yellow A enhances survival of vascular endothelial cells under hypoxia via upregulation of the HIF-1 alpha-VEGF pathway and regulation of Bcl-2/Bax.
Ji DB; Zhu MC; Zhu B; Zhu YZ; Li CL; Ye J; Zhu HB
J Cardiovasc Pharmacol; 2008 Aug; 52(2):191-202. PubMed ID: 18670359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
